HC Wainwright Raises Replimune Group (NASDAQ:REPL) Price Target to $51.00

Replimune Group (NASDAQ:REPL – Get Rating) had its target price upped by HC Wainwright from $50.00 to $51.00 in a research report sent to investors on Monday morning, The Fly reports. HC Wainwright also issued estimates for Replimune Group’s Q1 2024 earnings at ($0.80) EPS, Q2 2024 earnings at ($0.84) EPS, Q3 2024 earnings at […]

Related Keywords

Piper Sandler ,Philip Astley Sparke ,Jeanm Franchi ,Colin Love ,Ameritas Investment Partners Inc ,Replimune Group Inc ,Replimune Group ,Insider Activity At Replimune Group ,Analyst Recommendations For Replimune Group ,News Ratings For Replimune Group Daily ,Group Plc ,Panagora Asset Management Inc ,Life Insurance Co ,Replimune Group Stock Down ,Nasdaq ,Securities Exchange Commission ,Institutional Trading Of Replimune Group ,Get Rating ,Group Stock Down ,Exchange Commission ,General Group Plc ,Investment Partners ,Asset Management ,Robert Coffin ,Replimune Group Daily ,